Clinical Trial Update: Combining Varenicline and Naltrexone for Smoking Cessation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on combining varenicline and naltrexone for nicotine dependence and alcohol use disorder; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Nicotine Dependence

Drugs mentioned

• Naltrexone (Naltrexone)
• Varenicline (varenicline)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Nicotine Dependence, Alcohol Use Disorder | Phase 2 | Status: COMPLETED | Results posted: 2021-06-15